Diazepam updated on 02-10-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Congenital heart defects1.15 [1.03, 1.29]6%7 studies97,38020,029not evaluable ROB1.57 [1.21; .]
Cleft lip with or without cleft palate1.58 [0.92, 2.71]61%6 studies4,309146not evaluable ROB-
Cleft palate0.96 [0.50, 1.83]0%6 studies1,955103not evaluable ROB-
All congenital malformations (majors, minors, majors and minors, or unspecified)1.18 [0.99, 1.41]75%5 studies209,45620,008not evaluable ROB-
Major congenital malformations1.18 [0.99, 1.41]75%5 studies209,45620,008not evaluable ROB-
Oro-facial clefts1.65 [0.28, 9.92]61%3 studies1782,024not evaluable ROB-
Ano-rectal atresia and stenosis1.30 [0.18, 9.45]56%3 studies1,08134not evaluable ROB-
Eye defects0.87 [0.16, 4.71]43%2 studies211,159not evaluable ROB-
Neural Tube Defects0.65 [0.20, 2.16]52%3 studies2,16235not evaluable ROB-
Oesophageal atresia with or without tracheo-oesophageal fistula1.67 [0.60, 4.63]0%3 studies76235not evaluable ROB-
Atresia or stenosis of other parts of small intestine1.09 [0.41, 2.90]0%2 studies816not evaluable ROB-
Diaphragmatic hernia1.31 [0.35, 4.81]0%2 studies87736not evaluable ROB-
Gastroschisis0.77 [0.29, 2.04]0%2 studies1,40019not evaluable ROB-
Hydrocephaly1.37 [0.55, 3.39]0%2 studies51319not evaluable ROB-
Limb reduction defects (LRD)2.46 [0.86, 7.03]40%2 studies4216not evaluable ROB-
Omphalocele0.99 [0.19, 5.16]0%2 studies45135not evaluable ROB-
Ventricular septal defect0.81 [0.24, 2.79]0%2 studies1,79829not evaluable ROB-
Microcephaly / Small head circumference for gestational age--0 study-
26 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Preterm (< 37 weeks)1.13 [1.07, 1.20]-1 study228,89113,534not evaluable ROB1.51 [1.33; .]
Small for gestational age (weight)1.25 [1.18, 1.33]-1 study272,10911,021not evaluable ROB1.81 [1.63; .]

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions2.11 [1.11, 4.02]56%2 studies27,14927not evaluable ROB3.64 [1.46; .]
Late intrauterine deaths (> 22 weeks) / Stillbirths1.46 [1.26, 1.69]-1 study26,60313,726not evaluable ROB2.28 [1.83; .]